Delivery Order SPE2DB20D3103-SPE2DB23FP4U7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $49,486.13 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Plaquenil 200 mg tablets. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $90,494.47 firm fixed-price delivery order is for the supply of 4,560,160,597 units of Plaquenil 200 mg tablets. The award has a performance period through March 7, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.16 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used to treat various conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,909.44 firm fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used to treat certain types of malaria, lupus, and arthritis. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,726.73, is for the delivery of Plaquenil 200 mg tablets, a medication used to treat certain medical conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,820.34 firm fixed-price delivery order covers the supply of Plaquenil 200 mg tablets to support federal healthcare programs, with a completion date of September 2, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,687.48 firm fixed price Delivery Order (SPE2DB23FN7U6) is for the supply of 4,561,315,651 Plaquenil 200 mg tablets, with a completion date of June 23, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (SPE2DB20D3103) with the DLA Troop Support Medical, which...
- This federal contract award, with an ID of SPE2DX15D2101|SPE2DX23F50EY, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $89,465.01 contract is for the delivery of Plaquenil 200 mg tablets in quantities of 100s. This is a firm fixed-price delivery order contract with a performance period ending on March 23, 2023. The contract was not designated with any set-aside requirements,...
- This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FJ6A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,525.27 firm-fixed-price delivery order is for the supply of Plaquenil 200 mg tablets, a medication used for the treatment of malaria, lupus, and certain types of arthritis. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,101.97 firm fixed-price delivery order is for the pharmaceutical product Plaquenil 200 mg Tablet, with a completion date of June 5, 2023. The contract was awarded on June 2, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP4U7Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP4U7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The $37,074.61 firm fixed-price delivery order is for the supply of 4,561,920,233 units of the prescription drug Plaquenil 200 mg tablets. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.1k | 8/23/23 |